These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31005728)

  • 1. Exercise-induced anti-inflammatory effects in overweight/obese women with polycystic ovary syndrome.
    Dantas WS; Neves WD; Gil S; Barcellos CRG; Rocha MP; de Sá-Pinto AL; Roschel H; Gualano B
    Cytokine; 2019 Aug; 120():66-70. PubMed ID: 31005728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
    PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory environment and role of TNF-α in endometrial function of obese women having polycystic ovarian syndrome.
    Oróstica L; Astorga I; Plaza-Parrochia F; Vera C; García V; Carvajal R; Gabler F; Romero C; Vega M
    Int J Obes (Lond); 2016 Nov; 40(11):1715-1722. PubMed ID: 27569685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome.
    Mizgier M; Jarząbek-Bielecka G; Wendland N; Jodłowska-Siewert E; Nowicki M; Brożek A; Kędzia W; Formanowicz D; Opydo-Szymaczek J
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise.
    Covington JD; Tam CS; Pasarica M; Redman LM
    Biochimie; 2016 May; 124():27-33. PubMed ID: 25446648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
    Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
    Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL; Stepto NK; Hutchison SK; Teede HJ
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.
    Nehir Aytan A; Bastu E; Demiral I; Bulut H; Dogan M; Buyru F
    Gynecol Endocrinol; 2016 Sep; 32(9):709-713. PubMed ID: 26951881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome.
    Dantas WS; Marcondes JA; Shinjo SK; Perandini LA; Zambelli VO; Neves WD; Barcellos CR; Rocha MP; Yance Vdos R; Pereira RT; Murai IH; Pinto AL; Roschel H; Gualano B
    Obesity (Silver Spring); 2015 Nov; 23(11):2207-15. PubMed ID: 26373822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
    Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B
    Gynecol Endocrinol; 2021 Jan; 37(1):26-30. PubMed ID: 32544011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.
    Escobar-Morreale HF; Botella-Carretero JI; Villuendas G; Sancho J; San Millán JL
    J Clin Endocrinol Metab; 2004 Feb; 89(2):806-11. PubMed ID: 14764799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome.
    Agacayak E; Tunc SY; Sak S; Basaranoglu S; Yüksel H; Turgut A; Gul T
    Med Sci Monit; 2015 Aug; 21():2446-55. PubMed ID: 26292090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome.
    Rissanen AP; Koskela-Koivisto T; Hägglund H; Koponen AS; Aho JM; Pöyhönen-Alho M; Tiitinen A; Tikkanen HO; Peltonen JE
    Physiol Rep; 2016 Feb; 4(4):. PubMed ID: 26884479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
    Joham AE; Teede HJ; Hutchison SK; Stepto NK; Harrison CL; Strauss BJ; Paul E; Watt MJ
    Obesity (Silver Spring); 2012 Dec; 20(12):2390-6. PubMed ID: 22641183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.